Xvivo Perfusion (Sweden) Alpha and Beta Analysis

XVIVO Stock  SEK 451.50  5.50  1.23%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Xvivo Perfusion AB. It also helps investors analyze the systematic and unsystematic risks associated with investing in Xvivo Perfusion over a specified time horizon. Remember, high Xvivo Perfusion's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Xvivo Perfusion's market risk premium analysis include:
Beta
0.87
Alpha
(0.35)
Risk
2.04
Sharpe Ratio
(0.10)
Expected Return
(0.21)
Please note that although Xvivo Perfusion alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Xvivo Perfusion did 0.35  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Xvivo Perfusion AB stock's relative risk over its benchmark. Xvivo Perfusion AB has a beta of 0.87  . Xvivo Perfusion returns are very sensitive to returns on the market. As the market goes up or down, Xvivo Perfusion is expected to follow. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Xvivo Perfusion Backtesting, Xvivo Perfusion Valuation, Xvivo Perfusion Correlation, Xvivo Perfusion Hype Analysis, Xvivo Perfusion Volatility, Xvivo Perfusion History and analyze Xvivo Perfusion Performance.

Xvivo Perfusion Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Xvivo Perfusion market risk premium is the additional return an investor will receive from holding Xvivo Perfusion long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Xvivo Perfusion. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Xvivo Perfusion's performance over market.
α-0.35   β0.87

Xvivo Perfusion expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Xvivo Perfusion's Buy-and-hold return. Our buy-and-hold chart shows how Xvivo Perfusion performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Xvivo Perfusion Market Price Analysis

Market price analysis indicators help investors to evaluate how Xvivo Perfusion stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xvivo Perfusion shares will generate the highest return on investment. By understating and applying Xvivo Perfusion stock market price indicators, traders can identify Xvivo Perfusion position entry and exit signals to maximize returns.

Xvivo Perfusion Return and Market Media

The median price of Xvivo Perfusion for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 is 498.5 with a coefficient of variation of 5.36. The daily time series for the period is distributed with a sample standard deviation of 26.18, arithmetic mean of 488.16, and mean deviation of 22.27. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Xvivo Perfusion Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Xvivo or other stocks. Alpha measures the amount that position in Xvivo Perfusion AB has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Xvivo Perfusion in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Xvivo Perfusion's short interest history, or implied volatility extrapolated from Xvivo Perfusion options trading.

Build Portfolio with Xvivo Perfusion

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Xvivo Stock Analysis

When running Xvivo Perfusion's price analysis, check to measure Xvivo Perfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xvivo Perfusion is operating at the current time. Most of Xvivo Perfusion's value examination focuses on studying past and present price action to predict the probability of Xvivo Perfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xvivo Perfusion's price. Additionally, you may evaluate how the addition of Xvivo Perfusion to your portfolios can decrease your overall portfolio volatility.